nodes	percent_of_prediction	percent_of_DWPC	metapath
Propylthiouracil—MPO—superior mesenteric artery—pancreatic cancer	0.248	0.824	CbGeAlD
Propylthiouracil—TPO—digestive system—pancreatic cancer	0.0219	0.0729	CbGeAlD
Propylthiouracil—TPO—Hematopoietic Stem Cell Differentiation—ABO—pancreatic cancer	0.0182	0.106	CbGpPWpGaD
Propylthiouracil—Nephritis—Erlotinib—pancreatic cancer	0.0174	0.033	CcSEcCtD
Propylthiouracil—TPO—Hematopoietic Stem Cell Differentiation—ACVR1B—pancreatic cancer	0.0159	0.0928	CbGpPWpGaD
Propylthiouracil—Pigmentation disorder—Sunitinib—pancreatic cancer	0.0154	0.0292	CcSEcCtD
Propylthiouracil—DIO1—Selenium Metabolism and Selenoproteins—NFE2L2—pancreatic cancer	0.0149	0.0867	CbGpPWpGaD
Propylthiouracil—DBH—digestive system—pancreatic cancer	0.0143	0.0475	CbGeAlD
Propylthiouracil—MPO—IL23-mediated signaling events—IL24—pancreatic cancer	0.0133	0.0774	CbGpPWpGaD
Propylthiouracil—Lung infiltration—Erlotinib—pancreatic cancer	0.0127	0.024	CcSEcCtD
Propylthiouracil—Interstitial pneumonia—Tamoxifen—pancreatic cancer	0.0124	0.0235	CcSEcCtD
Propylthiouracil—Interstitial pneumonia—Erlotinib—pancreatic cancer	0.0123	0.0233	CcSEcCtD
Propylthiouracil—Lung infiltration—Irinotecan—pancreatic cancer	0.00904	0.0171	CcSEcCtD
Propylthiouracil—MPO—pancreas—pancreatic cancer	0.00894	0.0298	CbGeAlD
Propylthiouracil—Lung infiltration—Gemcitabine—pancreatic cancer	0.00881	0.0167	CcSEcCtD
Propylthiouracil—Drug fever—Docetaxel—pancreatic cancer	0.00878	0.0166	CcSEcCtD
Propylthiouracil—Interstitial pneumonia—Gemcitabine—pancreatic cancer	0.00855	0.0162	CcSEcCtD
Propylthiouracil—Interstitial lung disease—Tamoxifen—pancreatic cancer	0.00849	0.0161	CcSEcCtD
Propylthiouracil—Interstitial lung disease—Erlotinib—pancreatic cancer	0.0084	0.0159	CcSEcCtD
Propylthiouracil—MPO—digestive system—pancreatic cancer	0.00764	0.0254	CbGeAlD
Propylthiouracil—TPO—Differentiation Pathway—SHH—pancreatic cancer	0.00753	0.0439	CbGpPWpGaD
Propylthiouracil—Liver injury—Tamoxifen—pancreatic cancer	0.00714	0.0135	CcSEcCtD
Propylthiouracil—DIO1—Amino acid and derivative metabolism—ARG2—pancreatic cancer	0.00696	0.0406	CbGpPWpGaD
Propylthiouracil—Ageusia—Sunitinib—pancreatic cancer	0.00635	0.012	CcSEcCtD
Propylthiouracil—Vasculitis—Tamoxifen—pancreatic cancer	0.00616	0.0117	CcSEcCtD
Propylthiouracil—Interstitial pneumonia—Docetaxel—pancreatic cancer	0.00606	0.0115	CcSEcCtD
Propylthiouracil—Pigmentation disorder—Epirubicin—pancreatic cancer	0.00592	0.0112	CcSEcCtD
Propylthiouracil—Interstitial lung disease—Gemcitabine—pancreatic cancer	0.00584	0.011	CcSEcCtD
Propylthiouracil—DBH—Monoamine Transport—TSC2—pancreatic cancer	0.00575	0.0336	CbGpPWpGaD
Propylthiouracil—Neuritis—Gemcitabine—pancreatic cancer	0.00553	0.0105	CcSEcCtD
Propylthiouracil—Pigmentation disorder—Doxorubicin—pancreatic cancer	0.00548	0.0104	CcSEcCtD
Propylthiouracil—DIO1—Selenium Micronutrient Network—SOD2—pancreatic cancer	0.00501	0.0292	CbGpPWpGaD
Propylthiouracil—Hepatic failure—Tamoxifen—pancreatic cancer	0.00485	0.00919	CcSEcCtD
Propylthiouracil—Hepatic failure—Erlotinib—pancreatic cancer	0.0048	0.00909	CcSEcCtD
Propylthiouracil—Renal failure acute—Erlotinib—pancreatic cancer	0.00468	0.00885	CcSEcCtD
Propylthiouracil—Erythema nodosum—Epirubicin—pancreatic cancer	0.00457	0.00866	CcSEcCtD
Propylthiouracil—DBH—Amino acid and derivative metabolism—ARG2—pancreatic cancer	0.00425	0.0248	CbGpPWpGaD
Propylthiouracil—Vasculitis—Gemcitabine—pancreatic cancer	0.00423	0.00801	CcSEcCtD
Propylthiouracil—Erythema nodosum—Doxorubicin—pancreatic cancer	0.00423	0.00801	CcSEcCtD
Propylthiouracil—Hepatic failure—Sunitinib—pancreatic cancer	0.00416	0.00787	CcSEcCtD
Propylthiouracil—Interstitial lung disease—Docetaxel—pancreatic cancer	0.00414	0.00784	CcSEcCtD
Propylthiouracil—TPO—Hematopoietic Stem Cell Differentiation—NOTCH1—pancreatic cancer	0.00409	0.0238	CbGpPWpGaD
Propylthiouracil—Renal failure acute—Sunitinib—pancreatic cancer	0.00405	0.00766	CcSEcCtD
Propylthiouracil—TPO—Amino acid and derivative metabolism—ARG2—pancreatic cancer	0.004	0.0233	CbGpPWpGaD
Propylthiouracil—Neuritis—Docetaxel—pancreatic cancer	0.00393	0.00743	CcSEcCtD
Propylthiouracil—Ageusia—Docetaxel—pancreatic cancer	0.00362	0.00685	CcSEcCtD
Propylthiouracil—TPO—Differentiation Pathway—NOTCH1—pancreatic cancer	0.00353	0.0206	CbGpPWpGaD
Propylthiouracil—TPO—Differentiation Pathway—EGF—pancreatic cancer	0.00341	0.0199	CbGpPWpGaD
Propylthiouracil—Hepatic failure—Gemcitabine—pancreatic cancer	0.00334	0.00632	CcSEcCtD
Propylthiouracil—Renal failure acute—Irinotecan—pancreatic cancer	0.00333	0.00631	CcSEcCtD
Propylthiouracil—Dermatitis exfoliative—Irinotecan—pancreatic cancer	0.00326	0.00618	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Erlotinib—pancreatic cancer	0.00326	0.00617	CcSEcCtD
Propylthiouracil—Haemoglobin—Tamoxifen—pancreatic cancer	0.00303	0.00574	CcSEcCtD
Propylthiouracil—Haemorrhage—Tamoxifen—pancreatic cancer	0.00302	0.00571	CcSEcCtD
Propylthiouracil—Hepatitis—Tamoxifen—pancreatic cancer	0.00302	0.00571	CcSEcCtD
Propylthiouracil—Haemoglobin—Erlotinib—pancreatic cancer	0.003	0.00568	CcSEcCtD
Propylthiouracil—Hepatitis—Erlotinib—pancreatic cancer	0.00299	0.00565	CcSEcCtD
Propylthiouracil—Haemorrhage—Erlotinib—pancreatic cancer	0.00299	0.00565	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Sunitinib—pancreatic cancer	0.00282	0.00534	CcSEcCtD
Propylthiouracil—DIO1—Selenium Micronutrient Network—PTGS2—pancreatic cancer	0.00281	0.0164	CbGpPWpGaD
Propylthiouracil—MPO—Vitamin B12 Metabolism—SOD2—pancreatic cancer	0.00279	0.0163	CbGpPWpGaD
Propylthiouracil—MPO—IL23-mediated signaling events—NFKBIA—pancreatic cancer	0.00275	0.0161	CbGpPWpGaD
Propylthiouracil—Alopecia—Tamoxifen—pancreatic cancer	0.00267	0.00505	CcSEcCtD
Propylthiouracil—Neuritis—Epirubicin—pancreatic cancer	0.00265	0.00501	CcSEcCtD
Propylthiouracil—Alopecia—Erlotinib—pancreatic cancer	0.00264	0.005	CcSEcCtD
Propylthiouracil—DBH—Monoamine Transport—TNF—pancreatic cancer	0.00261	0.0152	CbGpPWpGaD
Propylthiouracil—Haemoglobin—Sunitinib—pancreatic cancer	0.0026	0.00492	CcSEcCtD
Propylthiouracil—Haemorrhage—Sunitinib—pancreatic cancer	0.00259	0.00489	CcSEcCtD
Propylthiouracil—Hepatitis—Sunitinib—pancreatic cancer	0.00259	0.00489	CcSEcCtD
Propylthiouracil—Dysgeusia—Tamoxifen—pancreatic cancer	0.00257	0.00487	CcSEcCtD
Propylthiouracil—Skin ulcer—Epirubicin—pancreatic cancer	0.00254	0.00481	CcSEcCtD
Propylthiouracil—Neuritis—Doxorubicin—pancreatic cancer	0.00245	0.00464	CcSEcCtD
Propylthiouracil—Ageusia—Epirubicin—pancreatic cancer	0.00244	0.00462	CcSEcCtD
Propylthiouracil—Hepatic failure—Docetaxel—pancreatic cancer	0.00237	0.00448	CcSEcCtD
Propylthiouracil—Leukopenia—Tamoxifen—pancreatic cancer	0.00235	0.00445	CcSEcCtD
Propylthiouracil—Skin ulcer—Doxorubicin—pancreatic cancer	0.00235	0.00445	CcSEcCtD
Propylthiouracil—Liver injury—Epirubicin—pancreatic cancer	0.00235	0.00445	CcSEcCtD
Propylthiouracil—Jaundice—Irinotecan—pancreatic cancer	0.00231	0.00438	CcSEcCtD
Propylthiouracil—MPO—Vitamin B12 Metabolism—APOE—pancreatic cancer	0.00229	0.0133	CbGpPWpGaD
Propylthiouracil—Alopecia—Sunitinib—pancreatic cancer	0.00228	0.00433	CcSEcCtD
Propylthiouracil—MPO—Folate Metabolism—SOD2—pancreatic cancer	0.00227	0.0132	CbGpPWpGaD
Propylthiouracil—Neuropathy peripheral—Gemcitabine—pancreatic cancer	0.00226	0.00429	CcSEcCtD
Propylthiouracil—Ageusia—Doxorubicin—pancreatic cancer	0.00226	0.00428	CcSEcCtD
Propylthiouracil—Myalgia—Tamoxifen—pancreatic cancer	0.00224	0.00424	CcSEcCtD
Propylthiouracil—Arthralgia—Tamoxifen—pancreatic cancer	0.00224	0.00424	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Fluorouracil—pancreatic cancer	0.00223	0.00422	CcSEcCtD
Propylthiouracil—Arthralgia—Erlotinib—pancreatic cancer	0.00221	0.00419	CcSEcCtD
Propylthiouracil—Myalgia—Erlotinib—pancreatic cancer	0.00221	0.00419	CcSEcCtD
Propylthiouracil—Dysgeusia—Sunitinib—pancreatic cancer	0.0022	0.00417	CcSEcCtD
Propylthiouracil—Liver injury—Doxorubicin—pancreatic cancer	0.00217	0.00412	CcSEcCtD
Propylthiouracil—Agranulocytosis—Gemcitabine—pancreatic cancer	0.00216	0.00408	CcSEcCtD
Propylthiouracil—Oedema—Tamoxifen—pancreatic cancer	0.00214	0.00406	CcSEcCtD
Propylthiouracil—Haemoglobin—Irinotecan—pancreatic cancer	0.00214	0.00405	CcSEcCtD
Propylthiouracil—Haemorrhage—Irinotecan—pancreatic cancer	0.00213	0.00403	CcSEcCtD
Propylthiouracil—Oedema—Erlotinib—pancreatic cancer	0.00212	0.00402	CcSEcCtD
Propylthiouracil—Agranulocytosis—Fluorouracil—pancreatic cancer	0.00212	0.00401	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.0021	0.00398	CcSEcCtD
Propylthiouracil—Haemoglobin—Gemcitabine—pancreatic cancer	0.00208	0.00395	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Erlotinib—pancreatic cancer	0.00208	0.00393	CcSEcCtD
Propylthiouracil—Haemorrhage—Gemcitabine—pancreatic cancer	0.00207	0.00393	CcSEcCtD
Propylthiouracil—TPO—Differentiation Pathway—VEGFA—pancreatic cancer	0.00207	0.0121	CbGpPWpGaD
Propylthiouracil—Haemoglobin—Fluorouracil—pancreatic cancer	0.00205	0.00388	CcSEcCtD
Propylthiouracil—Haemorrhage—Fluorouracil—pancreatic cancer	0.00204	0.00386	CcSEcCtD
Propylthiouracil—Leukopenia—Sunitinib—pancreatic cancer	0.00201	0.00381	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Tamoxifen—pancreatic cancer	0.00195	0.0037	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Erlotinib—pancreatic cancer	0.00193	0.00366	CcSEcCtD
Propylthiouracil—Paraesthesia—Tamoxifen—pancreatic cancer	0.00193	0.00365	CcSEcCtD
Propylthiouracil—Myalgia—Sunitinib—pancreatic cancer	0.00192	0.00363	CcSEcCtD
Propylthiouracil—Arthralgia—Sunitinib—pancreatic cancer	0.00192	0.00363	CcSEcCtD
Propylthiouracil—DIO1—Selenium Micronutrient Network—TNF—pancreatic cancer	0.0019	0.0111	CbGpPWpGaD
Propylthiouracil—TPO—Differentiation Pathway—TGFB1—pancreatic cancer	0.0019	0.0111	CbGpPWpGaD
Propylthiouracil—Dyspepsia—Tamoxifen—pancreatic cancer	0.00189	0.00357	CcSEcCtD
Propylthiouracil—Alopecia—Irinotecan—pancreatic cancer	0.00188	0.00356	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—HES1—pancreatic cancer	0.00187	0.0109	CbGpPWpGaD
Propylthiouracil—Dyspepsia—Erlotinib—pancreatic cancer	0.00187	0.00354	CcSEcCtD
Propylthiouracil—Aplastic anaemia—Epirubicin—pancreatic cancer	0.00186	0.00351	CcSEcCtD
Propylthiouracil—Oedema—Sunitinib—pancreatic cancer	0.00184	0.00348	CcSEcCtD
Propylthiouracil—Alopecia—Gemcitabine—pancreatic cancer	0.00183	0.00347	CcSEcCtD
Propylthiouracil—MPO—Selenium Micronutrient Network—SOD2—pancreatic cancer	0.0018	0.0105	CbGpPWpGaD
Propylthiouracil—Alopecia—Fluorouracil—pancreatic cancer	0.0018	0.00341	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Sunitinib—pancreatic cancer	0.0018	0.0034	CcSEcCtD
Propylthiouracil—Aplastic anaemia—Doxorubicin—pancreatic cancer	0.00172	0.00325	CcSEcCtD
Propylthiouracil—Urticaria—Tamoxifen—pancreatic cancer	0.0017	0.00323	CcSEcCtD
Propylthiouracil—Lymphadenopathy—Epirubicin—pancreatic cancer	0.00168	0.00318	CcSEcCtD
Propylthiouracil—Body temperature increased—Erlotinib—pancreatic cancer	0.00168	0.00318	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.00167	0.00317	CcSEcCtD
Propylthiouracil—Vertigo—Irinotecan—pancreatic cancer	0.00167	0.00315	CcSEcCtD
Propylthiouracil—Leukopenia—Irinotecan—pancreatic cancer	0.00166	0.00314	CcSEcCtD
Propylthiouracil—Paraesthesia—Sunitinib—pancreatic cancer	0.00165	0.00312	CcSEcCtD
Propylthiouracil—Dyspepsia—Sunitinib—pancreatic cancer	0.00162	0.00306	CcSEcCtD
Propylthiouracil—Leukopenia—Gemcitabine—pancreatic cancer	0.00162	0.00306	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Docetaxel—pancreatic cancer	0.00161	0.00304	CcSEcCtD
Propylthiouracil—Jaundice—Docetaxel—pancreatic cancer	0.0016	0.00303	CcSEcCtD
Propylthiouracil—Hepatic failure—Epirubicin—pancreatic cancer	0.0016	0.00302	CcSEcCtD
Propylthiouracil—Leukopenia—Fluorouracil—pancreatic cancer	0.00159	0.00301	CcSEcCtD
Propylthiouracil—MPO—IL23-mediated signaling events—STAT3—pancreatic cancer	0.00158	0.00921	CbGpPWpGaD
Propylthiouracil—Lymphadenopathy—Doxorubicin—pancreatic cancer	0.00156	0.00295	CcSEcCtD
Propylthiouracil—Renal failure acute—Epirubicin—pancreatic cancer	0.00155	0.00294	CcSEcCtD
Propylthiouracil—Arthralgia—Gemcitabine—pancreatic cancer	0.00154	0.00291	CcSEcCtD
Propylthiouracil—Myalgia—Gemcitabine—pancreatic cancer	0.00154	0.00291	CcSEcCtD
Propylthiouracil—Agranulocytosis—Docetaxel—pancreatic cancer	0.00153	0.0029	CcSEcCtD
Propylthiouracil—Dermatitis exfoliative—Epirubicin—pancreatic cancer	0.00152	0.00288	CcSEcCtD
Propylthiouracil—Pruritus—Tamoxifen—pancreatic cancer	0.00152	0.00287	CcSEcCtD
Propylthiouracil—Oedema—Irinotecan—pancreatic cancer	0.00151	0.00286	CcSEcCtD
Propylthiouracil—Myalgia—Fluorouracil—pancreatic cancer	0.00151	0.00286	CcSEcCtD
Propylthiouracil—Pruritus—Erlotinib—pancreatic cancer	0.0015	0.00284	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Irinotecan—pancreatic cancer	0.00148	0.0028	CcSEcCtD
Propylthiouracil—Haemoglobin—Docetaxel—pancreatic cancer	0.00148	0.0028	CcSEcCtD
Propylthiouracil—Hepatic failure—Doxorubicin—pancreatic cancer	0.00148	0.0028	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—PRSS1—pancreatic cancer	0.00147	0.0086	CbGpPWpGaD
Propylthiouracil—Oedema—Gemcitabine—pancreatic cancer	0.00147	0.00279	CcSEcCtD
Propylthiouracil—Hepatitis—Docetaxel—pancreatic cancer	0.00147	0.00279	CcSEcCtD
Propylthiouracil—Haemorrhage—Docetaxel—pancreatic cancer	0.00147	0.00279	CcSEcCtD
Propylthiouracil—Body temperature increased—Sunitinib—pancreatic cancer	0.00145	0.00275	CcSEcCtD
Propylthiouracil—Oedema—Fluorouracil—pancreatic cancer	0.00145	0.00274	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.00144	0.00273	CcSEcCtD
Propylthiouracil—Renal failure acute—Doxorubicin—pancreatic cancer	0.00144	0.00272	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.00142	0.00269	CcSEcCtD
Propylthiouracil—Dermatitis exfoliative—Doxorubicin—pancreatic cancer	0.00141	0.00266	CcSEcCtD
Propylthiouracil—MPO—IL23-mediated signaling events—TNF—pancreatic cancer	0.00137	0.00797	CbGpPWpGaD
Propylthiouracil—Vomiting—Tamoxifen—pancreatic cancer	0.00136	0.00258	CcSEcCtD
Propylthiouracil—Paraesthesia—Irinotecan—pancreatic cancer	0.00136	0.00257	CcSEcCtD
Propylthiouracil—Rash—Tamoxifen—pancreatic cancer	0.00135	0.00256	CcSEcCtD
Propylthiouracil—Dermatitis—Tamoxifen—pancreatic cancer	0.00135	0.00256	CcSEcCtD
Propylthiouracil—Vomiting—Erlotinib—pancreatic cancer	0.00135	0.00255	CcSEcCtD
Propylthiouracil—Somnolence—Irinotecan—pancreatic cancer	0.00134	0.00255	CcSEcCtD
Propylthiouracil—Headache—Tamoxifen—pancreatic cancer	0.00134	0.00254	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.00134	0.00254	CcSEcCtD
Propylthiouracil—Rash—Erlotinib—pancreatic cancer	0.00134	0.00253	CcSEcCtD
Propylthiouracil—Dermatitis—Erlotinib—pancreatic cancer	0.00134	0.00253	CcSEcCtD
Propylthiouracil—Dyspepsia—Irinotecan—pancreatic cancer	0.00133	0.00252	CcSEcCtD
Propylthiouracil—Headache—Erlotinib—pancreatic cancer	0.00133	0.00252	CcSEcCtD
Propylthiouracil—Paraesthesia—Gemcitabine—pancreatic cancer	0.00132	0.00251	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.00132	0.0025	CcSEcCtD
Propylthiouracil—Somnolence—Gemcitabine—pancreatic cancer	0.00131	0.00248	CcSEcCtD
Propylthiouracil—Paraesthesia—Fluorouracil—pancreatic cancer	0.0013	0.00246	CcSEcCtD
Propylthiouracil—Alopecia—Docetaxel—pancreatic cancer	0.0013	0.00246	CcSEcCtD
Propylthiouracil—Pruritus—Sunitinib—pancreatic cancer	0.0013	0.00246	CcSEcCtD
Propylthiouracil—Somnolence—Fluorouracil—pancreatic cancer	0.00129	0.00244	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—ARG2—pancreatic cancer	0.00128	0.00746	CbGpPWpGaD
Propylthiouracil—Dyspepsia—Fluorouracil—pancreatic cancer	0.00128	0.00241	CcSEcCtD
Propylthiouracil—Nausea—Tamoxifen—pancreatic cancer	0.00127	0.00241	CcSEcCtD
Propylthiouracil—Nausea—Erlotinib—pancreatic cancer	0.00126	0.00239	CcSEcCtD
Propylthiouracil—Dysgeusia—Docetaxel—pancreatic cancer	0.00125	0.00238	CcSEcCtD
Propylthiouracil—MPO—IL23-mediated signaling events—PIK3CA—pancreatic cancer	0.00125	0.00727	CbGpPWpGaD
Propylthiouracil—Body temperature increased—Irinotecan—pancreatic cancer	0.0012	0.00226	CcSEcCtD
Propylthiouracil—Vomiting—Sunitinib—pancreatic cancer	0.00117	0.00221	CcSEcCtD
Propylthiouracil—Body temperature increased—Gemcitabine—pancreatic cancer	0.00116	0.00221	CcSEcCtD
Propylthiouracil—Rash—Sunitinib—pancreatic cancer	0.00116	0.00219	CcSEcCtD
Propylthiouracil—Dermatitis—Sunitinib—pancreatic cancer	0.00116	0.00219	CcSEcCtD
Propylthiouracil—Urticaria—Fluorouracil—pancreatic cancer	0.00115	0.00218	CcSEcCtD
Propylthiouracil—Headache—Sunitinib—pancreatic cancer	0.00115	0.00218	CcSEcCtD
Propylthiouracil—Leukopenia—Docetaxel—pancreatic cancer	0.00115	0.00217	CcSEcCtD
Propylthiouracil—Body temperature increased—Fluorouracil—pancreatic cancer	0.00115	0.00217	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—CDKN2A—pancreatic cancer	0.00112	0.00656	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—TYMP—pancreatic cancer	0.00112	0.00652	CbGpPWpGaD
Propylthiouracil—Drowsiness—Epirubicin—pancreatic cancer	0.00111	0.00209	CcSEcCtD
Propylthiouracil—Myalgia—Docetaxel—pancreatic cancer	0.00109	0.00207	CcSEcCtD
Propylthiouracil—Arthralgia—Docetaxel—pancreatic cancer	0.00109	0.00207	CcSEcCtD
Propylthiouracil—Nausea—Sunitinib—pancreatic cancer	0.00109	0.00207	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.00108	0.00205	CcSEcCtD
Propylthiouracil—Jaundice—Epirubicin—pancreatic cancer	0.00108	0.00204	CcSEcCtD
Propylthiouracil—MPO—Vitamin B12 Metabolism—TNF—pancreatic cancer	0.00106	0.00617	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—PTGS2—pancreatic cancer	0.00105	0.00613	CbGpPWpGaD
Propylthiouracil—Oedema—Docetaxel—pancreatic cancer	0.00105	0.00198	CcSEcCtD
Propylthiouracil—Pruritus—Gemcitabine—pancreatic cancer	0.00104	0.00197	CcSEcCtD
Propylthiouracil—Agranulocytosis—Epirubicin—pancreatic cancer	0.00103	0.00195	CcSEcCtD
Propylthiouracil—Pruritus—Fluorouracil—pancreatic cancer	0.00103	0.00194	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Docetaxel—pancreatic cancer	0.00102	0.00194	CcSEcCtD
Propylthiouracil—Drowsiness—Doxorubicin—pancreatic cancer	0.00102	0.00194	CcSEcCtD
Propylthiouracil—MPO—Selenium Micronutrient Network—PTGS2—pancreatic cancer	0.00101	0.00591	CbGpPWpGaD
Propylthiouracil—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.001	0.0019	CcSEcCtD
Propylthiouracil—Haemoglobin—Epirubicin—pancreatic cancer	0.000998	0.00189	CcSEcCtD
Propylthiouracil—Jaundice—Doxorubicin—pancreatic cancer	0.000997	0.00189	CcSEcCtD
Propylthiouracil—Haemorrhage—Epirubicin—pancreatic cancer	0.000993	0.00188	CcSEcCtD
Propylthiouracil—Hepatitis—Epirubicin—pancreatic cancer	0.000993	0.00188	CcSEcCtD
Propylthiouracil—Vomiting—Irinotecan—pancreatic cancer	0.000962	0.00182	CcSEcCtD
Propylthiouracil—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000955	0.00181	CcSEcCtD
Propylthiouracil—Rash—Irinotecan—pancreatic cancer	0.000954	0.00181	CcSEcCtD
Propylthiouracil—Dermatitis—Irinotecan—pancreatic cancer	0.000953	0.0018	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000953	0.0018	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—CCND1—pancreatic cancer	0.000949	0.00554	CbGpPWpGaD
Propylthiouracil—Headache—Irinotecan—pancreatic cancer	0.000948	0.00179	CcSEcCtD
Propylthiouracil—Paraesthesia—Docetaxel—pancreatic cancer	0.000939	0.00178	CcSEcCtD
Propylthiouracil—Vomiting—Gemcitabine—pancreatic cancer	0.000937	0.00177	CcSEcCtD
Propylthiouracil—Somnolence—Docetaxel—pancreatic cancer	0.00093	0.00176	CcSEcCtD
Propylthiouracil—Rash—Gemcitabine—pancreatic cancer	0.000929	0.00176	CcSEcCtD
Propylthiouracil—Dermatitis—Gemcitabine—pancreatic cancer	0.000928	0.00176	CcSEcCtD
Propylthiouracil—Haemoglobin—Doxorubicin—pancreatic cancer	0.000923	0.00175	CcSEcCtD
Propylthiouracil—Headache—Gemcitabine—pancreatic cancer	0.000923	0.00175	CcSEcCtD
Propylthiouracil—Vomiting—Fluorouracil—pancreatic cancer	0.000921	0.00174	CcSEcCtD
Propylthiouracil—Dyspepsia—Docetaxel—pancreatic cancer	0.000921	0.00174	CcSEcCtD
Propylthiouracil—Haemorrhage—Doxorubicin—pancreatic cancer	0.000919	0.00174	CcSEcCtD
Propylthiouracil—Hepatitis—Doxorubicin—pancreatic cancer	0.000919	0.00174	CcSEcCtD
Propylthiouracil—Rash—Fluorouracil—pancreatic cancer	0.000914	0.00173	CcSEcCtD
Propylthiouracil—Dermatitis—Fluorouracil—pancreatic cancer	0.000913	0.00173	CcSEcCtD
Propylthiouracil—Headache—Fluorouracil—pancreatic cancer	0.000908	0.00172	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—GLP1R—pancreatic cancer	0.000901	0.00525	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PRSS1—pancreatic cancer	0.000901	0.00525	CbGpPWpGaD
Propylthiouracil—Nausea—Irinotecan—pancreatic cancer	0.000899	0.0017	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—DPYD—pancreatic cancer	0.000886	0.00517	CbGpPWpGaD
Propylthiouracil—Alopecia—Epirubicin—pancreatic cancer	0.000877	0.00166	CcSEcCtD
Propylthiouracil—Nausea—Gemcitabine—pancreatic cancer	0.000875	0.00166	CcSEcCtD
Propylthiouracil—Nausea—Fluorouracil—pancreatic cancer	0.000861	0.00163	CcSEcCtD
Propylthiouracil—MPO—Folate Metabolism—TNF—pancreatic cancer	0.00086	0.00502	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PRSS1—pancreatic cancer	0.000847	0.00494	CbGpPWpGaD
Propylthiouracil—Dysgeusia—Epirubicin—pancreatic cancer	0.000846	0.0016	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—SLC2A2—pancreatic cancer	0.000841	0.0049	CbGpPWpGaD
Propylthiouracil—Body temperature increased—Docetaxel—pancreatic cancer	0.000827	0.00157	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—NRAS—pancreatic cancer	0.000818	0.00477	CbGpPWpGaD
Propylthiouracil—Alopecia—Doxorubicin—pancreatic cancer	0.000812	0.00154	CcSEcCtD
Propylthiouracil—Dysgeusia—Doxorubicin—pancreatic cancer	0.000783	0.00148	CcSEcCtD
Propylthiouracil—DBH—Metabolism—ARG2—pancreatic cancer	0.000781	0.00455	CbGpPWpGaD
Propylthiouracil—Vertigo—Epirubicin—pancreatic cancer	0.000776	0.00147	CcSEcCtD
Propylthiouracil—Leukopenia—Epirubicin—pancreatic cancer	0.000774	0.00146	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—MYC—pancreatic cancer	0.000762	0.00444	CbGpPWpGaD
Propylthiouracil—MPO—Folate Metabolism—TP53—pancreatic cancer	0.000759	0.00442	CbGpPWpGaD
Propylthiouracil—Pruritus—Docetaxel—pancreatic cancer	0.00074	0.0014	CcSEcCtD
Propylthiouracil—Arthralgia—Epirubicin—pancreatic cancer	0.000736	0.00139	CcSEcCtD
Propylthiouracil—Myalgia—Epirubicin—pancreatic cancer	0.000736	0.00139	CcSEcCtD
Propylthiouracil—TPO—Metabolism—ARG2—pancreatic cancer	0.000734	0.00428	CbGpPWpGaD
Propylthiouracil—Vertigo—Doxorubicin—pancreatic cancer	0.000718	0.00136	CcSEcCtD
Propylthiouracil—Leukopenia—Doxorubicin—pancreatic cancer	0.000716	0.00136	CcSEcCtD
Propylthiouracil—Oedema—Epirubicin—pancreatic cancer	0.000705	0.00134	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—KRAS—pancreatic cancer	0.000704	0.0041	CbGpPWpGaD
Propylthiouracil—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000691	0.00131	CcSEcCtD
Propylthiouracil—MPO—Selenium Micronutrient Network—TNF—pancreatic cancer	0.000683	0.00399	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—TYMP—pancreatic cancer	0.000683	0.00398	CbGpPWpGaD
Propylthiouracil—Arthralgia—Doxorubicin—pancreatic cancer	0.000681	0.00129	CcSEcCtD
Propylthiouracil—Myalgia—Doxorubicin—pancreatic cancer	0.000681	0.00129	CcSEcCtD
Propylthiouracil—Vomiting—Docetaxel—pancreatic cancer	0.000665	0.00126	CcSEcCtD
Propylthiouracil—Rash—Docetaxel—pancreatic cancer	0.000659	0.00125	CcSEcCtD
Propylthiouracil—Dermatitis—Docetaxel—pancreatic cancer	0.000659	0.00125	CcSEcCtD
Propylthiouracil—Headache—Docetaxel—pancreatic cancer	0.000655	0.00124	CcSEcCtD
Propylthiouracil—Oedema—Doxorubicin—pancreatic cancer	0.000653	0.00124	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—CD44—pancreatic cancer	0.000651	0.0038	CbGpPWpGaD
Propylthiouracil—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000643	0.00122	CcSEcCtD
Propylthiouracil—TPO—Metabolism—TYMP—pancreatic cancer	0.000642	0.00374	CbGpPWpGaD
Propylthiouracil—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000639	0.00121	CcSEcCtD
Propylthiouracil—Paraesthesia—Epirubicin—pancreatic cancer	0.000633	0.0012	CcSEcCtD
Propylthiouracil—Somnolence—Epirubicin—pancreatic cancer	0.000627	0.00119	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—GCG—pancreatic cancer	0.000624	0.00364	CbGpPWpGaD
Propylthiouracil—Nausea—Docetaxel—pancreatic cancer	0.000621	0.00118	CcSEcCtD
Propylthiouracil—Dyspepsia—Epirubicin—pancreatic cancer	0.000621	0.00118	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—HRAS—pancreatic cancer	0.000598	0.00349	CbGpPWpGaD
Propylthiouracil—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000595	0.00113	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—STK11—pancreatic cancer	0.000587	0.00342	CbGpPWpGaD
Propylthiouracil—Paraesthesia—Doxorubicin—pancreatic cancer	0.000586	0.00111	CcSEcCtD
Propylthiouracil—Somnolence—Doxorubicin—pancreatic cancer	0.00058	0.0011	CcSEcCtD
Propylthiouracil—Dyspepsia—Doxorubicin—pancreatic cancer	0.000575	0.00109	CcSEcCtD
Propylthiouracil—Urticaria—Epirubicin—pancreatic cancer	0.00056	0.00106	CcSEcCtD
Propylthiouracil—Body temperature increased—Epirubicin—pancreatic cancer	0.000558	0.00106	CcSEcCtD
Propylthiouracil—DBH—Metabolism—GLP1R—pancreatic cancer	0.00055	0.00321	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—DPYD—pancreatic cancer	0.000541	0.00316	CbGpPWpGaD
Propylthiouracil—Urticaria—Doxorubicin—pancreatic cancer	0.000518	0.000982	CcSEcCtD
Propylthiouracil—TPO—Metabolism—GLP1R—pancreatic cancer	0.000517	0.00302	CbGpPWpGaD
Propylthiouracil—Body temperature increased—Doxorubicin—pancreatic cancer	0.000516	0.000977	CcSEcCtD
Propylthiouracil—DBH—Metabolism—SLC2A2—pancreatic cancer	0.000514	0.003	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—DPYD—pancreatic cancer	0.000509	0.00297	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—TYMS—pancreatic cancer	0.000505	0.00294	CbGpPWpGaD
Propylthiouracil—Pruritus—Epirubicin—pancreatic cancer	0.000499	0.000945	CcSEcCtD
Propylthiouracil—TPO—Metabolism—SLC2A2—pancreatic cancer	0.000483	0.00282	CbGpPWpGaD
Propylthiouracil—Pruritus—Doxorubicin—pancreatic cancer	0.000462	0.000874	CcSEcCtD
Propylthiouracil—Vomiting—Epirubicin—pancreatic cancer	0.000448	0.000849	CcSEcCtD
Propylthiouracil—Rash—Epirubicin—pancreatic cancer	0.000445	0.000842	CcSEcCtD
Propylthiouracil—Dermatitis—Epirubicin—pancreatic cancer	0.000444	0.000841	CcSEcCtD
Propylthiouracil—Headache—Epirubicin—pancreatic cancer	0.000442	0.000837	CcSEcCtD
Propylthiouracil—Nausea—Epirubicin—pancreatic cancer	0.000419	0.000793	CcSEcCtD
Propylthiouracil—Vomiting—Doxorubicin—pancreatic cancer	0.000415	0.000786	CcSEcCtD
Propylthiouracil—Rash—Doxorubicin—pancreatic cancer	0.000412	0.000779	CcSEcCtD
Propylthiouracil—Dermatitis—Doxorubicin—pancreatic cancer	0.000411	0.000778	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—APOE—pancreatic cancer	0.000411	0.00239	CbGpPWpGaD
Propylthiouracil—Headache—Doxorubicin—pancreatic cancer	0.000409	0.000774	CcSEcCtD
Propylthiouracil—DBH—Metabolism—CD44—pancreatic cancer	0.000398	0.00232	CbGpPWpGaD
Propylthiouracil—Nausea—Doxorubicin—pancreatic cancer	0.000388	0.000734	CcSEcCtD
Propylthiouracil—DBH—Metabolism—GCG—pancreatic cancer	0.000381	0.00222	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CD44—pancreatic cancer	0.000374	0.00218	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PIK3CG—pancreatic cancer	0.000371	0.00216	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GCG—pancreatic cancer	0.000359	0.00209	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—STK11—pancreatic cancer	0.000359	0.00209	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PPARG—pancreatic cancer	0.000358	0.00209	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—STK11—pancreatic cancer	0.000337	0.00197	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PIK3CD—pancreatic cancer	0.000326	0.0019	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—TYMS—pancreatic cancer	0.000308	0.0018	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—TYMS—pancreatic cancer	0.00029	0.00169	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PIK3CB—pancreatic cancer	0.000284	0.00166	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PTGS2—pancreatic cancer	0.000281	0.00164	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—APOE—pancreatic cancer	0.000251	0.00146	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PTEN—pancreatic cancer	0.000245	0.00143	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—APOE—pancreatic cancer	0.000236	0.00138	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PIK3CG—pancreatic cancer	0.000226	0.00132	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PPARG—pancreatic cancer	0.000218	0.00127	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PIK3CG—pancreatic cancer	0.000213	0.00124	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PPARG—pancreatic cancer	0.000205	0.0012	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PIK3CD—pancreatic cancer	0.000199	0.00116	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PIK3CD—pancreatic cancer	0.000187	0.00109	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PIK3CB—pancreatic cancer	0.000173	0.00101	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PIK3CA—pancreatic cancer	0.000173	0.00101	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PTGS2—pancreatic cancer	0.000172	0.001	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PIK3CB—pancreatic cancer	0.000163	0.000951	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PTGS2—pancreatic cancer	0.000162	0.000942	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PTEN—pancreatic cancer	0.00015	0.000874	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—AKT1—pancreatic cancer	0.000141	0.000825	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PTEN—pancreatic cancer	0.000141	0.000822	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PIK3CA—pancreatic cancer	0.000106	0.000617	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PIK3CA—pancreatic cancer	9.94e-05	0.00058	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—AKT1—pancreatic cancer	8.64e-05	0.000504	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—AKT1—pancreatic cancer	8.12e-05	0.000474	CbGpPWpGaD
